“…Nematicidal activity of chemotypes I and III was reported on Meloidogyne incognita at concentrations from 0.1-2.5 ml/L, which had mean mortality percentages from 22 to 100 %, in dependent dosage; and diminished eclosion rate from 47 to 9 % (Moreira, Santos, & Innecco, 2009). Antimicrobial and antifungal activity has been reported on periodontal-pathogenic microorganisms (Juiz et al, 2015;Bersan et al, 2014), cariogenic organisms (Bersan et al, 2014), enterobacteria (Pino, Ortega, Rosado, Rodríguez, & Baluja, 1996;Machado, Nogueira, Pereira, Sousa, & Batista, 2014), dermatophytes (Costa et al, 2014;Tangarife-Castaño et al, 2012), phytopathogens (Mena-Rodríguez, Ortega-Cuadros, Merini, Melo- Ríos, & Tofiño-Rivera, 2018;Anaruma et al, 2010), sulfate reductase (Souza et al, 2017a), important pathogens in aquiculture (Souza et al, 2017b;Majolo, Rocha, Chagas, Chaves, & Bizzo, 2017;Sutili et al, 2015), Candida albicans (Mesa-Arango et al, 2010;Santos et al, 2016a;Mesa-Arango et al, 2009), aspergillosis (Mesa-Arango et al, 2010;Glamočlija, Soković, Tešević, Linde, & Colauto, 2011;Mesa-Arango, et al, 2009), Cryptococcosis (Santos et al, 2016a); gastrointestinal, cutaneous, and nosocomial infections (Pino et al, 1996;Machado et al, 2014;Porfírio et al, 2017); under the MIC interval between 4.0-9 370 µg/ml and MBC 6.5-2 500 µg/ml for bacteria (Table 2), and MIC 31.25-2 000 and MBC/ MFC 500-1 250 µg/ml for fungus (Table 3). 2008), and is approved for over-the-counter sale as antiseptic for external use and adjuvant in the treatment of anxiety of nervous origin in humans (INVIMA, 2018).…”